International Patent: TREATMENT OF CARDIOMETABOLIC DISEASES USING METHODS TO LOWER PCSK9 EXPRESSION AND SECRETION BY TARGETING IP3R1

GENEVA, Nov. 6 -- MCMASTER UNIVERSITY filed a patent application (CA2026/050643) for “TREATMENT OF CARDIOMETABOLIC DISEASES USING METHODS TO LOWER PCSK9 EXPRESSION AND SECRETION BY TARGETING IP3R1”. With publication no. WO/2026/227178, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/713

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....